Quest Diagnostics (DGX) Tops Q1 EPS by 4c
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $246.28 -0.07%
Revenue Growth %: +7.8%
Financial Fact:
Equity earnings in unconsolidated joint ventures: 11M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +7.8%
Financial Fact:
Equity earnings in unconsolidated joint ventures: 11M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $1.40, $0.04 better than the analyst estimate of $1.36. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.87 billion.
- Outlook for full-year 2019 remains unchanged
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Ledyard Financial Group adds two directors, three retire
- Rubico to shift from semi-annual to quarterly financial reporting
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
